TY - JOUR
T1 - Cell Surface Proteomics of N-Linked Glycoproteins for Typing of Human Lymphocytes
AU - Haverland, Nicole A.
AU - Waas, Matthew
AU - Ntai, Ioanna
AU - Keppel, Theodore
AU - Gundry, Rebekah L.
AU - Kelleher, Neil L.
N1 - Funding Information:
Data are publicly available at MassIVE (massive.ucsd.edu; accession number MSV000080532). The authors would like to thank Alexandra J. Van-Nispenat Northwestern University for her critical review and feedback. This research was supported by the Paul G. Allen Family Foundation (Grant Award 11715) to N.L.K. and R.L.G., and NIH grants HL126785 and HL134010 to R.L.G.
Publisher Copyright:
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
PY - 2017/10
Y1 - 2017/10
N2 - Lymphocytes are immune cells that are critical for the maintenance of adaptive immunity. Differentiation of lymphoid progenitors yields B-, T-, and NK-cell subtypes that individually correlate with specific forms of leukemia or lymphoma. Therefore, it is imperative a precise method of cell categorization is utilized to detect differences in distinct disease states present in patients. One viable means of classification involves evaluation of the cell surface proteome of lymphoid malignancies. Specifically, this manuscript details the use of an antibody independent approach known as Cell Surface Capture Technology, to assess the N-glycoproteome of four human lymphocyte cell lines. Altogether, 404 cell surface N-glycoproteins were identified as markers for specific cell types involved in lymphocytic malignancies, including 82 N-glycoproteins that had not been previously been described for B or T cells within the Cell Surface Protein Atlas. Comparative analysis, hierarchical clustering techniques, and label-free quantitation were used to reveal proteins most informative for each cell type. Undoubtedly, the characterization of the cell surface proteome of lymphoid malignancies is a first step toward improving personalized diagnosis and treatment of leukemia and lymphoma.
AB - Lymphocytes are immune cells that are critical for the maintenance of adaptive immunity. Differentiation of lymphoid progenitors yields B-, T-, and NK-cell subtypes that individually correlate with specific forms of leukemia or lymphoma. Therefore, it is imperative a precise method of cell categorization is utilized to detect differences in distinct disease states present in patients. One viable means of classification involves evaluation of the cell surface proteome of lymphoid malignancies. Specifically, this manuscript details the use of an antibody independent approach known as Cell Surface Capture Technology, to assess the N-glycoproteome of four human lymphocyte cell lines. Altogether, 404 cell surface N-glycoproteins were identified as markers for specific cell types involved in lymphocytic malignancies, including 82 N-glycoproteins that had not been previously been described for B or T cells within the Cell Surface Protein Atlas. Comparative analysis, hierarchical clustering techniques, and label-free quantitation were used to reveal proteins most informative for each cell type. Undoubtedly, the characterization of the cell surface proteome of lymphoid malignancies is a first step toward improving personalized diagnosis and treatment of leukemia and lymphoma.
KW - N-glycoproteins
KW - cell surface proteins
KW - plasma membrane
UR - http://www.scopus.com/inward/record.url?scp=85030722078&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030722078&partnerID=8YFLogxK
U2 - 10.1002/pmic.201700156
DO - 10.1002/pmic.201700156
M3 - Article
C2 - 28834292
AN - SCOPUS:85030722078
SN - 1615-9853
VL - 17
JO - Proteomics
JF - Proteomics
IS - 19
M1 - 1700156
ER -